Kozak & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Sell |
1,541
-61
| -4% | -$4.32K | 0.02% | 106 |
|
|
2025
Q1 | $109K | Buy |
1,602
+1
| +0.1% | +$68 | 0.03% | 98 |
|
|
2024
Q4 | $106K | Buy |
1,601
+61
| +4% | +$4.04K | 0.02% | 97 |
|
|
2024
Q3 | $121K | Buy |
1,540
+9
| +0.6% | +$705 | 0.03% | 97 |
|
|
2024
Q2 | $118K | Hold |
1,531
| – | – | 0.03% | 91 |
|
|
2024
Q1 | $118K | Buy |
1,531
+23
| +2% | +$1.77K | 0.03% | 92 |
|
|
2023
Q4 | $101K | Hold |
1,508
| – | – | 0.03% | 102 |
|
|
2023
Q3 | $102K | Buy |
1,508
+48
| +3% | +$3.24K | 0.04% | 100 |
|
|
2023
Q2 | $95.3K | Hold |
1,460
| – | – | 0.04% | 109 |
|
|
2023
Q1 | $101K | Hold |
1,460
| – | – | 0.05% | 111 |
|
|
2022
Q4 | $99K | Hold |
1,460
| – | – | 0.05% | 109 |
|
|
2022
Q3 | $81K | Hold |
1,460
| – | – | 0.05% | 113 |
|
|
2022
Q2 | $96K | Hold |
1,460
| – | – | 0.06% | 108 |
|
|
2022
Q1 | $89K | Hold |
1,460
| – | – | 0.06% | 123 |
|
|
2021
Q4 | $89K | Hold |
1,460
| – | – | 0.06% | 123 |
|
|
2021
Q3 | $87K | Buy |
+1,460
| New | +$87K | 0.05% | 121 |
|